Michael L Alosco1, Thor D Stein1,2,3,4, Yorghos Tripodis1,5, Alicia S Chua5, Neil W Kowall1,2,3, Bertrand Russell Huber1,3,6, Lee E Goldstein1,2,7,8,9,10, Robert C Cantu1,11,12,13, Douglas I Katz1,14, Joseph N Palmisano1,15, Brett Martin1,15, Jonathan D Cherry1,2,3, Ian Mahar1, Ronald J Killiany1,16,17, Michael D McClean18, Rhoda Au1,16,19,20, Victor Alvarez1,3, Robert A Stern1,11,16, Jesse Mez1, Ann C McKee1,2,3,4. 1. Boston University Alzheimer's Disease Center and CTE Center, Department of Neurology, Boston University School of Medicine, Boston, Massachusetts. 2. Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts. 3. VA Boston Healthcare System, Boston, Massachusetts. 4. Bedford Veterans Affairs Medical Center, Bedford, Massachusetts. 5. Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts. 6. National Center for Posttraumatic Stress Disorder, VA Boston Healthcare, Boston, Massachusetts. 7. Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts. 8. Department of Electrical & Computer Engineering, Boston University College of Engineering, Boston, Massachusetts. 9. Department of Ophthalmology, Boston University School of Medicine, Boston, Massachusetts. 10. Department of Biomedical Engineering, Boston University College of Engineering, Boston, Massachusetts. 11. Department of Neurosurgery, Boston University School of Medicine, Boston, Massachusetts. 12. Concussion Legacy Foundation, Boston, Massachusetts. 13. Department of Neurosurgery, Emerson Hospital, Concord, Massachusetts. 14. Braintree Rehabilitation Hospital, Braintree, Massachusetts. 15. Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, Massachusetts. 16. Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts. 17. Center for Biomedical Imaging, Boston University School of Medicine, Boston, Massachusetts. 18. Department of Environmental Health, Boston University School of Public Health, Boston, Massachusetts. 19. Framingham Heart Study, National Heart, Lung, and Blood Institute, Boston, Massachusetts. 20. Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts.
Abstract
IMPORTANCE: Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repetitive head impacts, including those from US football, that presents with cognitive and neuropsychiatric disturbances that can progress to dementia. Pathways to dementia in CTE are unclear and likely involve tau and nontau pathologic conditions. OBJECTIVE: To investigate the association of white matter rarefaction and cerebrovascular disease with dementia in deceased men older than 40 years who played football and had CTE. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study involves analyses of data from the ongoing Understanding Neurologic Injury and Traumatic Encephalopathy (UNITE) Study, which is conducted via and included brain donors from the Veterans Affairs-Boston University-Concussion Legacy Foundation brain bank between 2008 and 2017. An original sample of 224 men who had played football and were neuropathologically diagnosed with CTE was reduced after exclusion of those younger than 40 years and those missing data. EXPOSURES: The number of years of football play as a proxy for repetitive head impacts. MAIN OUTCOMES AND MEASURES: Neuropathological assessment of white matter rarefaction and arteriolosclerosis severity (on a scale of 0-3, where 3 is severe); number of infarcts, microinfarcts, and microbleeds; and phosphorylated tau accumulation determined by CTE stage and semiquantitative rating of dorsolateral frontal cortex (DLFC) neurofibrillary tangles (NFTs) (none or mild vs moderate or severe). Informant-based retrospective clinical interviews determined dementia diagnoses via diagnostic consensus conferences. RESULTS: A total of 180 men were included. The mean (SD) age of the sample at death was 67.9 (12.7) years. Of 180, 120 [66.7%]) were found to have had dementia prior to death. Moderate to severe white matter rarefaction (84 of 180 [46.6%]) and arteriolosclerosis (85 of 180 [47.2%]) were common; infarcts, microinfarcts, and microbleeds were not. A simultaneous equations regression model controlling for age and race showed that more years of play was associated with more severe white matter rarefaction (β, 0.16 [95% CI, 0.02-0.29]; P = .03) and greater phosphorylated tau accumulation (DLFC NFTs: β, 0.15 [95% CI, 0.004-0.30]; P = .04; CTE stage: β, 0.27 [95% CI, 0.14-0.41]; P < .001). White matter rarefaction (β, 0.16 [95% CI, 0.02-0.29]; P = .03) and DLFC NFTs (β, 0.16 [95% CI, 0.03-0.28]; P = .01) were associated with dementia. Arteriolosclerosis and years of play were not associated, but arteriolosclerosis was independently associated with dementia (β, 0.21 [95% CI, 0.07-0.35]; P = .003). CONCLUSIONS AND RELEVANCE: Among older men who had played football and had CTE, more years of football play were associated with more severe white matter rarefaction and greater DLFC NFT burden. White matter rarefaction, arteriolosclerosis, and DLFC NFTs were independently associated with dementia. Dementia in CTE is likely a result of neuropathologic changes, including white matter rarefaction and phosphorylated tau, associated with repetitive head impact and pathologic changes not associated with head trauma, such as arteriolosclerosis.
IMPORTANCE: Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repetitive head impacts, including those from US football, that presents with cognitive and neuropsychiatric disturbances that can progress to dementia. Pathways to dementia in CTE are unclear and likely involve tau and nontau pathologic conditions. OBJECTIVE: To investigate the association of white matter rarefaction and cerebrovascular disease with dementia in deceased men older than 40 years who played football and had CTE. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study involves analyses of data from the ongoing Understanding Neurologic Injury and Traumatic Encephalopathy (UNITE) Study, which is conducted via and included brain donors from the Veterans Affairs-Boston University-Concussion Legacy Foundation brain bank between 2008 and 2017. An original sample of 224 men who had played football and were neuropathologically diagnosed with CTE was reduced after exclusion of those younger than 40 years and those missing data. EXPOSURES: The number of years of football play as a proxy for repetitive head impacts. MAIN OUTCOMES AND MEASURES: Neuropathological assessment of white matter rarefaction and arteriolosclerosis severity (on a scale of 0-3, where 3 is severe); number of infarcts, microinfarcts, and microbleeds; and phosphorylated tau accumulation determined by CTE stage and semiquantitative rating of dorsolateral frontal cortex (DLFC) neurofibrillary tangles (NFTs) (none or mild vs moderate or severe). Informant-based retrospective clinical interviews determined dementia diagnoses via diagnostic consensus conferences. RESULTS: A total of 180 men were included. The mean (SD) age of the sample at death was 67.9 (12.7) years. Of 180, 120 [66.7%]) were found to have had dementia prior to death. Moderate to severe white matter rarefaction (84 of 180 [46.6%]) and arteriolosclerosis (85 of 180 [47.2%]) were common; infarcts, microinfarcts, and microbleeds were not. A simultaneous equations regression model controlling for age and race showed that more years of play was associated with more severe white matter rarefaction (β, 0.16 [95% CI, 0.02-0.29]; P = .03) and greater phosphorylated tau accumulation (DLFC NFTs: β, 0.15 [95% CI, 0.004-0.30]; P = .04; CTE stage: β, 0.27 [95% CI, 0.14-0.41]; P < .001). White matter rarefaction (β, 0.16 [95% CI, 0.02-0.29]; P = .03) and DLFC NFTs (β, 0.16 [95% CI, 0.03-0.28]; P = .01) were associated with dementia. Arteriolosclerosis and years of play were not associated, but arteriolosclerosis was independently associated with dementia (β, 0.21 [95% CI, 0.07-0.35]; P = .003). CONCLUSIONS AND RELEVANCE: Among older men who had played football and had CTE, more years of football play were associated with more severe white matter rarefaction and greater DLFC NFT burden. White matter rarefaction, arteriolosclerosis, and DLFC NFTs were independently associated with dementia. Dementia in CTE is likely a result of neuropathologic changes, including white matter rarefaction and phosphorylated tau, associated with repetitive head impact and pathologic changes not associated with head trauma, such as arteriolosclerosis.
Authors: Madeline Uretsky; Sylvain Bouix; Ronald J Killiany; Yorghos Tripodis; Brett Martin; Joseph Palmisano; Asim Z Mian; Karen Buch; Chad Farris; Daniel H Daneshvar; Brigid Dwyer; Lee Goldstein; Douglas Katz; Christopher Nowinski; Robert Cantu; Neil Kowall; Bertrand Russell Huber; Robert A Stern; Victor E Alvarez; Thor D Stein; Ann McKee; Jesse Mez; Michael L Alosco Journal: Neurology Date: 2021-11-24 Impact factor: 9.910
Authors: Sarah K Kaufman; Sarah Svirsky; Jonathan D Cherry; Ann C McKee; Marc I Diamond Journal: Acta Neuropathol Date: 2021-10-09 Impact factor: 17.088
Authors: Michael L Alosco; Jonathan D Cherry; Bertrand Russell Huber; Yorghos Tripodis; Zachary Baucom; Neil W Kowall; Nicole Saltiel; Lee E Goldstein; Douglas I Katz; Brigid Dwyer; Daniel H Daneshvar; Joseph N Palmisano; Brett Martin; Robert C Cantu; Robert A Stern; Victor E Alvarez; Jesse Mez; Thor D Stein; Ann C McKee Journal: Acta Neuropathol Date: 2020-08-11 Impact factor: 17.088
Authors: Allysa Warling; Riri Uchida; Hyunsoo Shin; Coby Dodelson; Madeleine E Garcia; N Beckett Shea-Shumsky; Sarah Svirsky; Morgan Pothast; Hunter Kelley; Cynthia M Schumann; Christine Brzezinski; Melissa D Bauman; Allyson Alexander; Ann C McKee; Thor D Stein; Matthew Schall; Bob Jacobs Journal: J Comp Neurol Date: 2020-09-23 Impact factor: 3.215
Authors: Keith R Spencer; Zachariah W Foster; Nazifa Abdul Rauf; Latease Guilderson; Derek Collins; James G Averill; Sean E Walker; Ian Robey; Jonathan D Cherry; Victor E Alvarez; Bertrand R Huber; Ann C McKee; Neil W Kowall; Christopher B Brady; Thor D Stein Journal: Brain Pathol Date: 2020-08-04 Impact factor: 6.508
Authors: Benjamin L Brett; Kevin M Koch; L Tugan Muftuler; Matthew Budde; Michael A McCrea; Timothy B Meier Journal: J Neurotrauma Date: 2020-11-10 Impact factor: 5.269
Authors: K Blake Chancellor; Sarah E Chancellor; Joseph E Duke-Cohan; Bertrand R Huber; Thor D Stein; Victor E Alvarez; Benjamin W Okaty; Susan M Dymecki; Ann C McKee Journal: Acta Neuropathol Date: 2021-05-21 Impact factor: 15.887
Authors: Jason W Adams; Michael L Alosco; Jesse Mez; Victor E Alvarez; Bertrand R Huber; Yorghos Tripodis; Charles H Adler; Carol Kubilius; Kerry A Cormier; Rebecca Mathais; Raymond Nicks; Hunter J Kelley; Nicole Saltiel; Madeline Uretsky; Evan Nair; Nurgul Aytan; Jonathan D Cherry; Christopher J Nowinski; Neil W Kowall; Lee E Goldstein; Brigid Dwyer; Douglas I Katz; Robert C Cantu; Robert A Stern; Ann C McKee; Thor D Stein Journal: Acta Neuropathol Date: 2020-09-17 Impact factor: 17.088
Authors: Douglas I Katz; Charles Bernick; David W Dodick; Jesse Mez; Megan L Mariani; Charles H Adler; Michael L Alosco; Laura J Balcer; Sarah J Banks; William B Barr; David L Brody; Robert C Cantu; Kristen Dams-O'Connor; Yonas E Geda; Barry D Jordan; Thomas W McAllister; Elaine R Peskind; Ronald C Petersen; Jennifer V Wethe; Ross D Zafonte; Éimear M Foley; Debra J Babcock; Walter J Koroshetz; Yorghos Tripodis; Ann C McKee; Martha E Shenton; Jeffrey L Cummings; Eric M Reiman; Robert A Stern Journal: Neurology Date: 2021-03-15 Impact factor: 11.800